Rabu, 14 Desember 2022

This is Why Pfizer is Still a Buy

Delta expects profit to nearly double next year on ‘robust’ air travel demand | Drop in U.S. import prices bolsters hopes of improving inflation outlook ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Logo

To ensure proper delivery of our emails, please include editor@dailystockbuzz.com within your contact list.

Today's Sponsors

Wall St. Legend’s Inflation-Crushing Secret

This inflation-beating method -- which I reveal for FREE in this presentation -- is going to be even more relevant in the months ahead. I want you to get educated… and get ready to weather the storm …

You can learn the full details by clicking here.

Bizarre 'Seismic Anomaly' Hitting U.S. Markets

One of the biggest market mysteries of the year is happening right now. It's something so bizarre that Fortune called it a "seismic anomaly." And if you own any U.S. assets – stocks, bonds, or cash savings – you MUST be aware of what's unfolding today …

Click here to see what's coming and how you should prepare now.

Top News

Drop in U.S. import prices bolsters hopes of improving inflation outlook

  Dec 14, 2022  

U.S. import prices fell for a fifth straight month in November, pulled down by declining costs for petroleum products and a strong dollar and supporting the view that inflation could continue to moderate in the months ahead ... Read more

Delta expects profit to nearly double next year on ‘robust’ air travel demand

  Dec 14, 2022  

Delta Air Lines Inc said on Wednesday its profit is expected to nearly double next year, driven by “robust” travel demand and a decline in non-fuel operating costs. The Atlanta-based carrier forecast an adjusted profit of $5 to $6 per share for 2023, up from an estimated $3.07 to $3.12 per share for this year ... Read more

This is Why Pfizer is Still a Buy

  Dec 14, 2022  

Pfizer (PFE) has gone ballistic. Since bottoming out at around $42 in October, the stock is now up to $53.33.  From here, it could move even higher on an upgrade from Goldman Sachs. The firm just upgraded PFE to a buy rating with a price target of $60 a share ... Read more

Tidak ada komentar:

Posting Komentar